Epigenetic therapy overcomes treatment resistance in T cell prolymphocytic leukemia
Science Translational Medicine | June 24, 2015 | Volume: 7 | Issue: 293 | Pages: No page available
10.1126/scitranslmed.aaa5079
Epigenetic drugs can overcome resistance to monoclonal antibodies in T-PLL and activate therapeutic targets for antibody-drug conjugates.